Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012 Aug 30;367(9):795-804. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Paper Alert: DIAN Biomarker Data Show Changes Decades Before AD
  2. In Big Picture, Familial AD’s Biomarker Data Resemble LOAD
  3. Multimodal Imaging: Structure, Function, Amyloid Not in Synch
  4. Expanding the Network, DIAN Starts Showing Longitudinal Data
  5. Data in Disguise: As Results Roll In, DIAN Works to Guard Privacy
  6. As DIAN’s Scope Widens, Funding Narrows
  7. Midlife CSF Crisis? Markers May Herald Future AD
  8. Tau Tracers Track First Emergence of Tangles in Familial Alzheimer’s
  9. Data from DIAN Revise Familiar Biomarker Trajectories
  10. In DIAN-TU, Gantenerumab Brings Down Tau. By a Lot. Open Extension Planned
  11. Gearing Up for Down’s Syndrome Clinical Trials

Research Timeline Event

  1. Prospective biomarker studies find 20-year prodrome in autosomal-dominant AD